In "The IDSA Guideline's Four-Step Antibiotic Selection Framework," the panel walks through the guideline's structured ...
D’Amico concluded that remigromig is the first biologic with a novel mechanism of action that demonstrated a noninferior ...
Community oncology practices need to move unstructured data into accessible fields before artificial intelligence (AI) can support clinical decisions, and they can judge AI purchases by whether a tool ...
AI tools are streamlining retina practice, but adoption depends on fitting them into real-world workflows.
Weill Cornell's Mateo Mejia Saldarriaga, MD, discusses patient preference for on-body isatuximab and how to sequence CAR T ...
A sarcoma-specific indocyanine green protocol using a signal-to-background ratio cut point of 1.67 identified 14 of 15 ...
Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...
A vote taken by the sound of applause rang out during an early morning session at (AAO) 2026 annual meeting, where 2 experts discussed the pros and cons of using complement inhibitors to treat ...
The Bimatoprost Drug Pad-IOL (BIM-IOL) System, developed by SpyGlass Pharma, uses 2 drug-eluting pads attached to the lens to ...